HR and neoplasm: ,15 Our stratified analysis further identifies specific NACT patient subgroups, including those with lobular/mixed histology and less aggressive tumor biology (eg, HR+/HER2−, well/moderately differentiated tumors, stage I), who exhibited greater mortality risk compared to ACT patients.